Aquilion system offers industry’s largest bore and widest field-of-view, potentially augmenting radiation therapy planning.
Canon Medical Systems received clearance from the U.S. Food & Drug Administration (FDA) Thursday for its Aquilion™ Exceed LB CT system that is designed to improve the planning and delivery of radiation therapy.
As an artificial intelligence-powered system, company officials said, Aquilion is intended to facilitate workflow while maintaining image quality and reproducibility.
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, CT business unit managing director for Canon Medical. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”
Based on company details, Aquilion offers several benefits: